# Indaco Capital

> Indaco Capital is a VC fund in Beijing backing Medical, Health Care and Biotechnology. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 5
- Last investment: Jan 2023
- Lead investor: 0%
- Last updated: Aug 2026
- Website: https://www.indacocapital.com/

Indaco Capital is an investment firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 3 | 60% |
| Health Care | 3 | 60% |
| Biotechnology | 3 | 60% |
| Pharmaceutical | 1 | 20% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 60% |
| Seed | 1 | 20% |
| Funding Round | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| ReLive Biotechnologies LTD | ReLive is a biotechnology company that develops orthopedic sports medicine and plastic and reconstructive surgery projects based on regenerative medicine and cell therapy science. | $43M | Series A | Jan 16, 2023 |  |
| Zenshine Pharma | Zenshine Pharma is a clinical-stage biopharmaceutical company with a focus on the development of small molecule drugs for cancer, viral infections, and autoimmune diseases. | $15M | Series A | Dec 01, 2020 |  |
| Delova Biotech | Delova Biotech specializes in the field of pain treatment. It uses the company's rich R&D experience and special preparation technology platform to improve existing drugs and conduct research and development of improved new analgesics in China and the United States. | $7.1M |  | Sep 21, 2020 |  |
| Delova Biotech | Delova Biotech specializes in the field of pain treatment. It uses the company's rich R&D experience and special preparation technology platform to improve existing drugs and conduct research and development of improved new analgesics in China and the United States. | $7.3M | Seed | Sep 21, 2020 |  |
| Acornmed | Acornmed provides clinical oncology solutions. |  | Series A | Apr 09, 2020 |  |

5 of 5 investments shown.

## Co-investors
- [Jiuyou Capital](https://shizune.co/investors/profile/jiuyou-capital) — VC Fund, 2 deals together
- [Legend Capital](https://shizune.co/investors/profile/legend-capital) — VC Fund, 2 deals together
- Dingshu Information Technology — VC Fund, 1 deal together
- [Ennovation Ventures](https://shizune.co/investors/profile/ennovation-ventures) — VC Fund, 1 deal together
- Lingxian Ziben — VC Fund, 1 deal together
- [Shanghai Biomedical Industrial Equity Investment Fund](https://shizune.co/investors/profile/shanghai-biomedical-industrial-equity-investment-fund) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Indaco Capital invest in?

Indaco Capital invests primarily in Medical, Health Care and Biotechnology startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Indaco Capital last invest?

The most recent investment recorded for Indaco Capital closed in Jan 2023. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co